Meanwhile Adamis Pharmaceuticals has been trying since May, 2014 to get FDA approval to market single dose, prefilled epinehrine syringes to ne used by patients in an emergency situation.
Their application has been rejected by the FDA twice.
“....Adamis Pharmaceuticals on Monday said federal regulators won’t yet consider its epinephrine shot for severe allergic reactions for approval, erasing nearly half of the company’s market value. Shares dropped 41% to $5.20 in premarket trading....”
see comment 56
Lots of thick smoke surrounding this Mylan CEO Heather Bresch issue.
But, I’m sure there’s no fire. Nope.
I will bet MONEY that Senator Daddy Joe Manchin said to the FDA...” SHUT DOWN MY DAUGHTER:S COMPETITION!! ANd you will get MORE MONET TO WASTE!!